Adaptimmune Therapeutics plc

NasdaqGS:ADAP Stock Report

Market Cap: US$178.4m

Adaptimmune Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ADAP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Jun 24SellUS$22,814Cintia PiccinaIndividual24,531US$0.93
17 Jan 24SellUS$15,889John LungerIndividual22,795US$0.79
17 Jan 24SellUS$16,423William C. BertrandIndividual23,589US$0.79
17 Jan 24SellUS$27,594Adrian G. RawcliffeIndividual39,384US$0.79
17 Jan 24SellUS$14,106Elliot NorryIndividual20,563US$0.79
12 Jan 24SellUS$24,734Adrian G. RawcliffeIndividual29,202US$0.85
12 Jan 24SellUS$10,015Elliot NorryIndividual11,808US$0.85
12 Jan 24SellUS$7,813John LungerIndividual9,229US$0.85
12 Jan 24SellUS$7,813William C. BertrandIndividual9,229US$0.85

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ADAP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,737,7420.679%
VC/PE Firms17,079,7786.67%
Institutions57,354,26722.4%
Hedge Funds78,385,47530.6%
General Public101,325,94539.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.7%.

Top Shareholders

Top 25 shareholders own 59.13% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.7%
Matrix Capital Management Company, LP
37,681,515US$26.3m-3.32%1.02%
10.7%
EcoR1 Capital, LLC
27,404,070US$19.1m0%0.61%
6.67%
New Enterprise Associates, Inc.
17,079,778US$11.9m0%0.49%
6.56%
Baillie Gifford & Co.
16,775,860US$11.7m10.7%no data
5.2%
Long Focus Capital Management LLC
13,299,890US$9.3m7.72%0.74%
3.91%
PFM Health Sciences, LP
10,000,787US$7.0m-4.94%0.42%
2.17%
MPM BioImpact LLC
5,555,461US$3.9m0%2.55%
1.99%
BioImpact Capital LLC
5,095,912US$3.6m0%0.53%
1.82%
Bank of America Corporation, Asset Management Arm
4,652,325US$3.2m0%no data
0.95%
Rock Springs Capital Management LP
2,425,468US$1.7m0%0.05%
0.66%
Morgan Stanley, Investment Banking and Brokerage Investments
1,698,740US$1.2m286%no data
0.65%
Renaissance Technologies LLC
1,656,575US$1.2m-7.26%no data
0.62%
Impresa Management LLC
1,578,783US$1.1m0%0.58%
0.39%
JP Morgan Asset Management
986,051US$687.4k28.1%no data
0.29%
U.S. Global Investors, Inc.
752,458US$524.5k0%0.03%
0.28%
Redmile Group, LLC
715,607US$498.8k0%0.03%
0.28%
Millennium Management LLC
715,350US$498.7k-8.24%no data
0.27%
Garry Menzel
686,295US$478.4k0%no data
0.2%
Marshall Wace LLP
522,608US$364.3k261%no data
0.17%
Rathbones Investment Management Limited
432,818US$301.7k0%no data
0.16%
State Street Global Advisors, Inc.
396,792US$276.6k1.51%no data
0.13%
Dafna Capital Management, LLC
341,064US$237.8k0%0.06%
0.12%
Helen Tayton-Martin
300,060US$209.2k0%no data
0.11%
BlackRock, Inc.
283,626US$197.7k46.4%no data
0.11%
Mercer Investments LLC
273,048US$190.3k0%no data